Filing Details

Accession Number:
0001138723-11-000060
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-10-07 21:25:40
Reporting Period:
2011-10-05
Filing Date:
2011-10-07
Accepted Time:
2011-10-07 21:25:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1138723 Accuray Inc ARAY Surgical & Medical Instruments & Apparatus (3841) 770268932
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1387516 Euan Thomson 1310 Chesapeake Terrace
Sunnyvale CA 94089
President & Ceo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-10-05 10,000 $0.75 244,130 No 4 M Direct
Common Stock Disposition 2011-10-05 10,000 $3.89 234,130 No 4 S Direct
Common Stock Acquisiton 2011-10-06 10,000 $0.75 244,130 No 4 M Direct
Common Stock Disposition 2011-10-06 10,000 $3.95 234,130 No 4 S Direct
Common Stock Acquisiton 2011-10-06 10,000 $2.50 244,130 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2011-10-06 10,000 $0.00 10,000 $2.50
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2011-10-05 10,000 $0.00 10,000 $0.75
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2011-10-06 10,000 $0.00 10,000 $0.75
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
41,899 2014-08-10 No 4 M Direct
432,501 2013-08-27 No 4 M Direct
422,501 2013-08-27 No 4 M Direct
Footnotes
  1. A portion of these options are being sold so that a portion of the proceeds may be used to increase the CEO's ownership of Accuray stock in accordance with the adoption of stock ownership guidelines for management by the Board of Directors of Accuray Incorporated in fiscal year 2011.
  2. The sale is pursuant to a 10b5-1 plan. The sale price represents the weighted average sale price. The shares were sold at prices ranging from $3.77 to $3.96 per share. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. The sale is pursuant to a 10b5-1 plan. The sale price represents the weighted average sale price. The shares were sold at prices ranging from $3.87 to $4.04 per share. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  4. These options are exercisable as they vest. The shares subject to this stock option become vested and fully exercisable in equal monthly installments, ratably over a period of 48-months.
  5. The options are exercisable as they vest. A total of 25% of the entire number of shares subject to this stock option becomes vested and fully exercisable on the first anniversary of the vesting commencement date and the remaining shares subject to this stock option vest and become exercisable in equal monthly installments, ratably over the following 36 months.